Janney Montgomery Scott LLC purchased a new stake in shares of Rani Therapeutics Holdings, Inc. (NASDAQ:RANI – Free Report) during the fourth quarter, according to the company in its most recent ...

Rani Therapeutics Holdings, Inc. (NASDAQ:RANI – Get Free Report) has been given an average recommendation of “Buy” by the six ratings firms that are currently covering the stock, Ratings reports. Five ...

These five health care stocks, all belonging to small- or micro-cap categories, notched the highest jump in Stocktwits ...

Lipella Pharmaceuticals LIPO shares increased by 158.9% to $6.68 during Thursday's pre-market session. The market value of their outstanding shares is at $8.0 million. MBX Biosciences MBX stock moved ...

Coherent reported quarterly earnings of 95 cents per share which beat the analyst consensus estimate of 69 cents per share. The company reported quarterly sales of $1.44 billion which beat the analyst ...

SAN JOSE, Calif. - Rani Therapeutics Holdings , Inc. (NASDAQ:RANI), a clinical-stage biotherapeutics company with a market capitalization of $48.3 million, today announced promising results from a ...

Oral semaglutide administered via the RaniPill® HC (RT-116) demonstrated comparable bioavailability, pharmacokinetics and ...

Rani Therapeutics (RANI) announced new pharmacokinetic and pharmacodynamic data from a preclinical study evaluating the oral delivery of the ...

Request To Download Free Sample of This Strategic Report @ Highlighted with 36 tables and 64 figures, this 150-page report Asia Pacific Digital Health and Wellness Market 2023-2033 by Product ...